269 related articles for article (PubMed ID: 19034316)
1. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes.
Henneman P; van der Sman-de Beer F; Moghaddam PH; Huijts P; Stalenhoef AF; Kastelein JJ; van Duijn CM; Havekes LM; Frants RR; van Dijk KW; Smelt AH
Eur J Hum Genet; 2009 May; 17(5):620-8. PubMed ID: 19034316
[TBL] [Abstract][Full Text] [Related]
2. Unraveling hyperlipidemia type III (dysbetalipoproteinemia), slowly.
Schaefer JR
Eur J Hum Genet; 2009 May; 17(5):541-2. PubMed ID: 19034315
[No Abstract] [Full Text] [Related]
3. Polymorphisms in the apolipoprotein A5 (APOA5) gene and type III hyperlipidemia.
Evans D; Seedorf U; Beil FU
Clin Genet; 2005 Oct; 68(4):369-72. PubMed ID: 16143024
[TBL] [Abstract][Full Text] [Related]
4. Cerebrovascular atherosclerosis in type III hyperlipidemia is modulated by variation in the apolipoprotein A5 gene.
Evans D; Bode A; von der Lippe G; Beil FU; Mann WA
Eur J Med Res; 2011 Feb; 16(2):79-84. PubMed ID: 21463987
[TBL] [Abstract][Full Text] [Related]
5. Expression of type III hyperlipoproteinemia in patients homozygous for apolipoprotein E-2 is modulated by lipoprotein lipase and postprandial hyperinsulinemia.
Brümmer D; Evans D; Berg D; Greten H; Beisiegel U; Mann WA
J Mol Med (Berl); 1998 Apr; 76(5):355-64. PubMed ID: 9587070
[TBL] [Abstract][Full Text] [Related]
6. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia.
Smith RC; Segman RH; Golcer-Dubner T; Pavlov V; Lerer B
Pharmacogenomics J; 2008 Jun; 8(3):228-36. PubMed ID: 17726453
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
8. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
[TBL] [Abstract][Full Text] [Related]
9. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
10. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
11. A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia.
Hegele RA; Ban MR; Hsueh N; Kennedy BA; Cao H; Zou GY; Anand S; Yusuf S; Huff MW; Wang J
Hum Mol Genet; 2009 Nov; 18(21):4189-94. PubMed ID: 19656773
[TBL] [Abstract][Full Text] [Related]
12. Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population.
Matsunaga A; Arishima H; Niimura H; Zhang B; Uehara Y; Ohwaki K; Morita M; Hayashida K; Saku K
Circ J; 2007 May; 71(5):746-52. PubMed ID: 17457003
[TBL] [Abstract][Full Text] [Related]
13. Rare variants in the lipoprotein lipase (LPL) gene are common in hypertriglyceridemia but rare in Type III hyperlipidemia.
Evans D; Arzer J; Aberle J; Beil FU
Atherosclerosis; 2011 Feb; 214(2):386-90. PubMed ID: 21159338
[TBL] [Abstract][Full Text] [Related]
14. The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.
Evans D; Beil FU
BMC Med Genet; 2007 Aug; 8():56. PubMed ID: 17727701
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
16. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of alleles encoding defective lipoprotein lipase in hypertriglyceridemic patients of French Canadian descent.
Minnich A; Kessling A; Roy M; Giry C; DeLangavant G; Lavigne J; Lussier-Cacan S; Davignon J
J Lipid Res; 1995 Jan; 36(1):117-24. PubMed ID: 7706936
[TBL] [Abstract][Full Text] [Related]
18. Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.
Charrière S; Cugnet C; Guitard M; Bernard S; Groisne L; Charcosset M; Pruneta-Deloche V; Merlin M; Billon S; Delay M; Sassolas A; Moulin P; Marçais C
Atherosclerosis; 2009 Nov; 207(1):150-6. PubMed ID: 19447388
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia.
De Castro-Orós I; Cenarro A; Tejedor MT; Baila-Rueda L; Mateo-Gallego R; Lamiquiz-Moneo I; Pocoví M; Civeira F
Circ Cardiovasc Genet; 2014 Dec; 7(6):814-21. PubMed ID: 25176936
[TBL] [Abstract][Full Text] [Related]
20. APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia.
Wang J; Ban MR; Kennedy BA; Anand S; Yusuf S; Huff MW; Pollex RL; Hegele RA
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):730-7. PubMed ID: 18779834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]